Articles Referencing ABT
GE and Three Others Named Top Dividend Growers of Last Week
6/17/2013, 6:30 pm from GuruFocus in Investing
During the past week, GuruFocus recognized four companies as
dividend growers. In order to be considered for this list, the
company had to: � Have a dividend yield of more... Read >>
Abbott Progresses with Absorb in Japan - Analyst Blog
6/14/2013, 6:30 pm from Zacks.com in Investing, Business, Stocks
Abbott Labs ( ABT ) recently
announced that it has initiated a randomized controlled study in
Japan to evaluate Absorb, its bioresorbable vascular scaffold (BVS)
device, in patients... Read >>
Bear of the Day: Covidien (COV) - Bear of the Day
6/12/2013, 5:02 am from Zacks.com in Investing, Investing Ideas, Stocks
In the wake of its dismal fiscal 2013 second quarter results,
analysts covering Covidien PLC ( COV ), the $30 billion
medical products maker, slashed earnings estimates for both this
year and... Read >>
After Hours Most Active for Jun 3, 2013 : MMR, BAC, FE, ZNGA, NOK, GNW, MSFT, QQQ, ABT, SIRI, INTC, DTV
6/3/2013, 4:44 pm from NASDAQ.com News in News Headlines, After Hours Most Active
The NASDAQ 100
After Hours Indicator is down -1.85 to 2,988.94. The total
After hours volume is currently 38,498,721 shares traded.
The following are the
most active stocks for the after... Read >>
Abbott Labs' HPV Test in Canada - Analyst Blog
5/31/2013, 5:27 pm from Zacks.com in Investing, Business, Stocks
Abbott Laboratories ( ABT ) recently
announced that the company obtained license for its RealTime High
Risk HPV molecular diagnostic test from the Medical Device Bureau
of Health Canada. ... Read >>
Stocks Market News for May 30, 2013 - Market News
5/30/2013, 10:29 am from Zacks.com in Investing, US Markets
Benchmarks slipped into the red after investors reduced their
holdings of high yielding dividend stocks. On Tuesday, major
indices gained following encouraging domestic reports. But
yesterday,... Read >>
Ken Fisher's First Quarter Top Increases and Decreases
5/29/2013, 6:26 pm from GuruFocus in Investing
Ken Fisher is the CEO and CIO of Fisher
Investments. During his many years of money management and market
commentary, Ken has distinguished himself by making numerous,
accurate market calls,... Read >>
Vanguard Cuts Fees on Popular Dividend ETF
5/28/2013, 4:14 pm from Benzinga in Investing, ETFs, Investing Ideas
Vanguard, the third-largest U.S. ETF sponsor, lowered the annual
expense ratio on its popular Vanguard Dividend Appreciation ETF
(NYSE: VIG ) to 0.1
percent from 0.13 percent effective... Read >>
CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog
5/22/2013, 7:26 pm from Zacks.com in Investing, Business, Stocks
Abbott Laboratories ( ABT ) recently
announced that it received CE Mark in Europe for its drug eluting
stent - Xience Xpedition 48 Everolimus Eluting Coronary Stent
System. Xience... Read >>
Covidien Provides 2013 Outlook - Analyst Blog
5/6/2013, 1:22 pm from Zacks.com in Investing, Business, Stocks
Covidien plc ( COV ) has revealed its
guidance for fiscal 2013 after adjusting for the spin-off of the
Pharmaceutical business, which is expected to take place at the end
of third quarter... Read >>
Amarin's Performance Issues: Here To Stay?
4/29/2013, 1:30 pm from SeekingAlpha in Investing, Stocks
ByDallas Salazar: Amarin Corporation ( AMRN ) is one of the
most controversial and debated stocks in recent memory. Plenty of
information exists that helps validate both the bull and bear... Read >>
Earnings Beat for ABAX, Sluggish Overall - Analyst Blog
4/26/2013, 4:00 pm from Zacks.com in Investing, Business, Earnings, Stocks
Provider of portable blood analysis systems for human and
veterinary patient-care, Abaxis Inc. ( ABAX ) reported
fourth-quarter fiscal 2013 earnings per share ("EPS") of 30... Read >>
Abbott - Epizyme Collaborate - Analyst Blog
4/23/2013, 6:10 pm from Zacks.com in Investing, Business, Stocks
Abbott Laboratories ( ABT )
recently announced a strategic deal with Epizyme, Inc. for the
development of a molecular companion diagnostic test for use with
EPZ-5676. EPZ-5676 is being... Read >>
New Product from Abbott Labs - Analyst Blog
4/22/2013, 6:09 pm from Zacks.com in Investing, Business, Stocks
Abbott Laboratories ( ABT ) recently
announced that the company has gained approval from the US Food and
Drug Administration (FDA) for its TECNIS Toric 1-Piece intraocular
lens (IOL). The... Read >>
Abbott Labs Recalls Glucose Meter - Analyst Blog
4/19/2013, 5:12 pm from Zacks.com in Investing, Business, Stocks
Abbott Laboratories ( ABT ) recently
announced that the company is initiating a voluntary recall of its
FreeStyle InsuLinx Blood Glucose Meters in the US. Abbott Labs decided to recall the... Read >>